Pharmacia/Fermenta
Executive Summary
Volvo's 40% interest in Pharmacia is being acquired by the Swedish biotech firm Fermenta. The transaction is reportedly valued at over $500 mil. "The intention is to create conditions for a concentration of effort and for a new structure for the Swedish biotechnology industry by forming a major corporate group, strong in resources, with well developed research operations, rationalized production, and worldwide market network," Pharmacia said in a press statement. The firm added that "since Fermenta has also made an offer for shares held by Volvo and others" in the Swedish industrial company Sonessons, Fermenta also will acquire a "large interest in the Swedish pharmaceutical companies Leo and Ferrosan".
You may also be interested in...
Keep Makena Under Accelerated Approval Pending More Studies, AMAG Tells US FDA
AMAG outlines plans for retrospective real-world evidence studies, and possibly a new placebo-controlled trial with a primary endpoint of preterm birth <32 weeks, in a filing opposing the Center for Drug Evaluation and Research’s proposal to withdraw the drug.
World-First Nod For Yuhan's Lung Cancer Drug, In Korea
The leading Korean pharma firm’s oral, third-generation EGFR-TKI is approved in the country, providing a new option for patients with advanced NSCLC and increasing hopes for global approvals given an ongoing global Phase III combination trial led by partner J&J.
DePuy Synthes Gains US FDA Clearance For Velys Robot For Total Knee Surgery
DePuy Synthes expects its Velys robotic-assisted system to be cost-effective, easy-to-use and to be well-suited for use in ambulatory surgery centers.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: